Profusa (PFSA) Non Operating Investment Income (2023)
Profusa (PFSA) posted quarterly Non Operating Investment Income of -$3165.0 for Q1 2023.
Profusa (PFSA) Non Operating Investment Income (2023) Analysis & Trends
Profusa's Non Operating Investment Income history runs 1 years deep, the most recent figure standing at -$3165.0 for Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Profusa | 124,279.61 | -250,720.39 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -3,165.00 |
| Mar 31, 2023 | -3,165.00 |